German laboratories study effect of Ukrainian medicines against coronavirus, - ambassador

Source : 112 Ukraine

Ukraine and Germany manage to agree on how to jointly fight the coronavirus pandemic
18:24, 11 May 2020
Open source
German laboratories are studying the effects of Ukrainian medicines, which are thought to be useful for treating Covid-19. This was stated by Ambassador of Ukraine to Germany Andriy Melnyk in an interview with Radio Liberty.

According to Melnyk, Ukraine and Germany managed to agree on how to jointly fight the coronavirus pandemic.

“We really have very good experience. It is in German laboratories that some domestic medicines that can be used to treat coronavirus are being tested. We are very active in this process, and I hope that there will be joint initiatives in the development of the vaccine, so we try to bring together our scientific institutions with leading centers operating in Germany," he said.

As previously reported, scientists have found that blood thinners can save patients with the severe form of Covid-19: doctors recorded a decrease in mortality among those patients who received anticoagulants.
Earlier German enterprise BioNTech and American company Pfizer have jointly developed an experimental vaccine against coronavirus. There's a chance it could reach the world's markets by the end of the year. Ugur Şahin, the BioNTech CEO said so in an interview with CNN.

“We see vaccine responses, we see strong vaccine responses at even low doses. And we believe that this vaccine response since we have seen that in different animal models will also translate into vaccine responses in human subjects," the official said.

The vaccine is already being tested on people in the U.S. and Germany.

According to Şahin, if the vaccine is approved by the governing authorities, partner companies will be ready to speed up its production and entrance to markets so that it becomes available for the population.

"Şahin believes Covid-19 will be responsive to a vaccine which is he calls the “most important aspect” of vaccine development. He said the second aspect is the “very encouraging” pre-clinical data," CNN wrote.

Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more